Re Alliance

Fulcrum Pharma PLC
07 September 2007





7th September 2007

                               FULCRUM PHARMA PLC
                         ('the Group' or 'the Company')


   Fulcrum and LORENZ in strategic alliance to develop and deliver 'Creative
                            eRegulatory SolutionsTM'

Fulcrum Pharma plc (AIM: FUL), the drug development and regulatory services
company is pleased to announce the intent to form a strategic alliance with
LORENZ Life Sciences Group.

Fulcrum is committed to developing new products and services which enable Pharma
and Biotech companies to achieve faster regulatory approval of new medicines.
LORENZ develops and markets software solutions for the life sciences industry
that are mainly geared towards submission assembly, review, publishing,
validation and management for regulated environments. LORENZ and Fulcrum believe
that tailored IT solutions are critically important for ensuring the quality of
pharmaceutical regulatory submissions and, if designed and applied
appropriately, can have a dramatic impact on the time to regulatory submission
and approval.

As a first step in the strategic alliance, the two companies have agreed to
establish a joint sales and marketing campaign in North America and Europe to
provide tailored e-publishing solutions in this growing market. The joint
product offering will combine the strategic regulatory and e-publishing skills
of Fulcrum with the submission management software solutions developed by
LORENZ. Together, the two companies will offer Creative eRegulatory SolutionsTM
in a cost-effective and tailored approach to new and existing clients.

Jon Court, Chief Executive of Fulcrum Pharma, said: 'Together we will be well
positioned to meet the increasing demand for regulatory services which comprise
an e-publishing component. The alliance with LORENZ will increase our capacity
to deliver e-products to our clients and enhance the reach of our regulatory
business. We look forward to this exciting partnership and the development of a
series of new regulatory products and services'

Wolfgang Witzel, President of Lorenz, said. 'This partnership provides a
tailored solution to meet our customers' needs, combining the regulatory skills
in Fulcrum with the e-publishing expertise in LORENZ. Working with Fulcrum will
enable us to enhance our regulatory product offering in a way that directly
benefits our clients. This is an exciting opportunity for both LORENZ and
Fulcrum'

For further information, please contact:

Fulcrum Pharma PLC
Jon Court, Chief Executive                     Tel: [phone]

Seymour Pierce
Jonathan Wright                                Tel: [phone]

About Fulcrum Pharma plc

Fulcrum Pharma plc is a drug development and regulatory services business that
provides global expertise to achieve drug development and regulatory approval
milestones.

Fulcrum Pharma offers immediate access to a highly credible, integrated
development team that provides strategic and operational leadership required to
ensure that new drugs move smoothly from discovery research to product approval

Fulcrum Pharma is listed on the AIM Market of the London Stock Exchange having
successfully floated in March 2000.

About Lorenz

LORENZ Life Sciences Group (www.lorenz.cc) develops and markets software
solutions for the Life Sciences market. LORENZ's solutions are geared
specifically for submission assembly, review, publishing, validation and
management. As the number one supplier of submission management systems in the
world for US, European and Japanese submissions, LORENZ is currently the market
leader in producing eCTDs. With over 100 installations in 20 countries, LORENZ
has built a reputable customer base. For more information, please contact Andre
Neu, [e-mail] in Europe and Yaprak Eisinger, [e-mail] in North
America.



                      This information is provided by RNS
            The company news service from the London Stock Exchange